Most adults should continue to pay nothing
out-of-pocket for COVID-19 vaccines. Uninsured/underinsured adults can receive vaccine at no cost at participating Bridge Access Program locations. Visit vaccines.gov to find a Bridge Access Program location.
This independent, nonprofit organization provides assistance to qualifying patients with financial hardship who generally have no prescription insurance.
Provides access and reimbursement support to patients taking BAVENCIO® (avelumab) injection in the United States.
CoverOne™ is brought to you by EMD Serono Inc. and Pfizer Inc.
Assists eligible patients with their co-pay costs.
*Terms and conditions apply. In some cases, patients may be only eligible for this co-pay or savings card if their prescription plan covers the Pfizer medicine they’ve been prescribed.
Offers Copay assistance for eligible patients treated with Pfizer Biosimilars.
Please contact the program directly for more information.
Helps patients understand their insurance for EUCRISA® (crisaborole) ointment, 2%, and also helps eligible patients save on their medicine.
*Patients must be at or below 400% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Helps patients understand their insurance for LITFULOTM (ritlecitinib) and also helps eligible patients save on their medicine.
Call 1-833-956-DERM (3376) or Visit Site
An online wholesaler that offers brand-name and generic medicines at significantly reduced prices.
The Myfembree® Support Program is designed to help your patients throughout their treatment journey. We offer financial assistance options, dedicated support staff, and other helpful resources once patients have been prescribed Myfembree®.
In this resource, the various components of the program will be described in detail to ensure that patients understand which offerings, if any, they are eligible for.
Call 1-833-MYFEMBREE (1-833-693-3627)
The Nurtec® Patient Assistance Program provides assistance to eligible patients who have been prescribed Nurtec®.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Call 1-866-473-0088
Helps eligible patients access NGENLA® (somatrogon-ghla).
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Helps eligible patients access SOMAVERT® (pegvisomant) for injection.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Helps eligible patients access GENOTROPIN® (somatropin) for injection
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Offers Copay assistance for eligible patients treated with Pfizer Biosimilars.
Please contact the program directly for more information.
Provides patients access to relevant Pfizer tools and programs based on their individual needs.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Call 1-888-733-2030 or Visit Site
Provides patients access to relevant Pfizer tools and programs based on their individual needs.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Provides patients with financial assistance and personalized support for their Pfizer oncology medicines:
BESPONSA™ (inotuzumab ozogamicin), BOSULIF® (bosutinib) tablets, BRAFTOVI® (encorafenib) capsules, DAURISMO™ (glasdegib) tablets, EMCYT® (estramustine phosphate sodium) capsules, IBRANCE® (palbociclib) capsules, INLYTA® (axitinib) tablets, LORBRENA® (lorlatinib) tablets, MEKTOVI® (binimetinib) tablets, MYLOTARG™ (gemtuzumab ozogamicin) for injection, TALZENNA® (talazoparib) capsules, TRAZIMERA™ (trastuzumab-qyyp) for injection, VIZIMPRO® (dacomitinib) tablets, XALKORI® (crizotinib) capsules, and
Copay medicines only:
AROMASIN® (exemestane) tablets, NIVESTYM® (filgrastim-aafi) injection, NYVEPRIA™ (pegfilgrastim-apgf) injection, RUXIENCE™ (rituximab-pvvr) injection, SUTENT® (sunitinib malate) capsules and ZIRABEV™ (bevacizumab-bvzr) injection
Helps verify patients’ insurance benefits and their understanding of coverage requirements for ABRYSVO™ (Respiratory Syncytial Virus Vaccine), PREVNAR 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), TRUMENBA® (Meningococcal Group B Vaccine) and Prevnar 20™ (Pneumococcal 20-valent Conjugate Vaccine).
Helps verify patients’ insurance benefits and their understanding of coverage requirements for ABRYSVO™ (Respiratory Syncytial Virus Vaccine), PREVNAR 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), TRUMENBA® (Meningococcal Group B Vaccine) and Prevnar 20™ (Pneumococcal 20-valent Conjugate Vaccine).
Assists eligible patients with their co-pay costs.
Terms and conditions apply. In some cases, patients may be only eligible for this co-pay or savings card if their prescription plan covers the Pfizer medicine they've been prescribed.
Call 1-855-440-6852 or Visit Site
Pfizer IGuide Phone: 1-844-448-4337, Fax: 1-844-868-6329, Hours: Monday-Friday (excluding holidays) 8 am to 8 pm ET.
Provides assistance to eligible* patients who have been prescribed VELSIPITY™ (etrasimod) tablets.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Helps eligible patients who have been prescribed VYNDAMAX™ (tafamidis) research financial assistance resources, and identify third-party resources that may be available.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Provides assistance to eligible patients who have been prescribed XELJANZ® (tofacitinib) tablets/XELJANZ® XR (tofacitinib) extended-release tablets.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
The Zavzpret™ Patient Assistance Program provides assistance to eligible patients who have been prescribed Zavzpret™.
*Patients must be at or below 300% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Call 1-866-473-0088
